Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Passarelli MN, Barry EL, Rees JR, Mott LA, Zhang D, Ahnen DJ, Bresalier RS, Haile RW, McKeown-Eyssen G, Snover DC, Cole BF, Baron JA.

Am J Clin Nutr. 2019 Aug 10. pii: nqz160. doi: 10.1093/ajcn/nqz160. [Epub ahead of print]

PMID:
31401653
2.

Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.

Ahern TP, Broe A, Lash TL, Cronin-Fenton DP, Ulrichsen SP, Christiansen PM, Cole BF, Tamimi RM, Sørensen HT, Damkier P.

J Clin Oncol. 2019 Jul 20;37(21):1800-1809. doi: 10.1200/JCO.18.02202. Epub 2019 Apr 17.

PMID:
30995175
3.

Applications of Noninferiority Trials in Interventional Pulmonology.

Mahajan AK, Ost DE, Cole BF, Kinsey CM.

J Bronchology Interv Pulmonol. 2019 Jan;26(1):6-9. doi: 10.1097/LBR.0000000000000554. No abstract available.

PMID:
30562280
4.

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01.

Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.

PMID:
30196031
5.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

6.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

Karlsson P, Cole BF, Price KN, Gelber RD, Coates AS, Goldhirsch A, Castiglione M, Colleoni M, Gruber G; International Breast Cancer Study Group.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):273-279. doi: 10.1016/j.ijrobp.2016.06.2448.

7.

Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer.

Kinsey CM, San José Estépar R, van der Velden J, Cole BF, Christiani DC, Washko GR.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):38-43. doi: 10.1158/1055-9965.EPI-15-1067. Epub 2016 May 19.

8.

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes.

Yip WK, Bonetti M, Cole BF, Barcella W, Wang XV, Lazar A, Gelber RD.

Clin Trials. 2016 Aug;13(4):382-90. doi: 10.1177/1740774516643297. Epub 2016 Apr 19.

9.

Ultrasound-Guided Versus Blind Subacromial Corticosteroid Injections for Subacromial Impingement Syndrome: A Randomized, Double-Blind Clinical Trial.

Cole BF, Peters KS, Hackett L, Murrell GA.

Am J Sports Med. 2016 Mar;44(3):702-7. doi: 10.1177/0363546515618653. Epub 2015 Dec 30.

PMID:
26717970
10.

Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP.

Lazar AA, Bonetti M, Cole BF, Yip WK, Gelber RD.

Clin Trials. 2016 Apr;13(2):169-79. doi: 10.1177/1740774515609106. Epub 2015 Oct 22.

11.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

12.

Symptoms of endocrine treatment and outcome in the BIG 1-98 study.

Huober J, Cole BF, Rabaglio M, Giobbie-Hurder A, Wu J, Ejlertsen B, Bonnefoi H, Forbes JF, Neven P, Láng I, Smith I, Wardley A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Gelber RD, Thürlimann B; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Breast Cancer Res Treat. 2014 Jan;143(1):159-69. doi: 10.1007/s10549-013-2792-7. Epub 2013 Dec 5.

13.

Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' reply.

Galimberti V, Cole BF.

Lancet Oncol. 2013 Jun;14(7):e251-2. doi: 10.1016/S1470-2045(13)70241-9. No abstract available.

PMID:
23725705
14.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators.

Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Erratum in: Lancet Oncol. 2013 Jun;14(7):e254.

15.

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.

Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T.

Breast Cancer Res Treat. 2012 Dec;136(3):919-26. doi: 10.1007/s10549-012-2333-9. Epub 2012 Nov 11.

PMID:
23143284
16.

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.

Karlsson P, Cole BF, Chua BH, Price KN, Lindtner J, Collins JP, Kovács A, Thürlimann B, Crivellari D, Castiglione-Gertsch M, Forbes JF, Gelber RD, Goldhirsch A, Gruber G; International Breast Cancer Study Group.

Ann Oncol. 2012 Nov;23(11):2852-8. doi: 10.1093/annonc/mds118. Epub 2012 Jul 9.

17.

Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.

Lazar AA, Cole BF, Bonetti M, Gelber RD.

J Clin Oncol. 2010 Oct 10;28(29):4539-44. doi: 10.1200/JCO.2009.27.9182. Epub 2010 Sep 13.

18.

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

Karlsson P, Cole BF, Colleoni M, Roncadin M, Chua BH, Murray E, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gruber G; International Breast Cancer Study Group.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):398-402. doi: 10.1016/j.ijrobp.2010.02.042. Epub 2010 Aug 21.

19.

Native MAG-1 antibody almost destroys human breast cancer xenografts.

North WG, Pang RH, Gao G, Memoli VA, Cole BF.

Breast Cancer Res Treat. 2011 Jun;127(3):631-7. doi: 10.1007/s10549-010-1009-6. Epub 2010 Jul 13.

20.

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Colleoni M, Cole BF, Viale G, Regan MM, Price KN, Maiorano E, Mastropasqua MG, Crivellari D, Gelber RD, Goldhirsch A, Coates AS, Gusterson BA.

J Clin Oncol. 2010 Jun 20;28(18):2966-73. doi: 10.1200/JCO.2009.25.9549. Epub 2010 May 10.

21.

Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.

Paridaens RJ, Gelber S, Cole BF, Gelber RD, Thürlimann B, Price KN, Holmberg SB, Crivellari D, Coates AS, Goldhirsch A.

Breast Cancer Res Treat. 2010 Aug;123(1):303-10. doi: 10.1007/s10549-010-0794-2. Epub 2010 Feb 27.

22.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM.

Clin Colorectal Cancer. 2009 Apr;8(2):100-5.

23.

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.

Schwaab T, Schwarzer A, Wolf B, Crocenzi TS, Seigne JD, Crosby NA, Cole BF, Fisher JL, Uhlenhake JC, Mellinger D, Foster C, Szczepiorkowski ZM, Webber SM, Schned AR, Harris RD, Barth RJ Jr, Heaney JA, Noelle RJ, Ernstoff MS.

Clin Cancer Res. 2009 Aug 1;15(15):4986-92. doi: 10.1158/1078-0432.CCR-08-3240. Epub 2009 Jul 21.

24.

A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.

Barth RJ Jr, Wells WA, Mitchell SE, Cole BF.

Ann Surg Oncol. 2009 Aug;16(8):2288-94. doi: 10.1245/s10434-009-0489-2. Epub 2009 May 8.

25.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM.

Clin Colorectal Cancer. 2009 Mar;8(2):100-5.

PMID:
19423503
26.

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):256-66. doi: 10.1093/jnci/djn485. Epub 2009 Feb 10.

27.

A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.

Bonetti M, Zahrieh D, Cole BF, Gelber RD.

Stat Med. 2009 Apr 15;28(8):1255-68. doi: 10.1002/sim.3524.

29.

Gastrin, Helicobacter pylori, and colorectal adenomas.

Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):163-7. doi: 10.1016/j.cgh.2008.09.006. Epub 2008 Sep 20.

PMID:
18929688
30.

MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.

Levine AJ, Wallace K, Tsang S, Haile RW, Saibil F, Ahnen D, Cole BF, Barry EL, Munroe DJ, Ali IU, Ueland P, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2409-15. doi: 10.1158/1055-9965.EPI-07-2670.

31.

Another STEPP in the right direction.

Bonetti M, Cole BF, Gelber RD.

J Clin Oncol. 2008 Aug 1;26(22):3813-4; author reply 3814-5. doi: 10.1200/JCO.2008.17.8467. No abstract available.

PMID:
18669475
32.

A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme.

Fadul CE, Kingman LS, Meyer LP, Cole BF, Eskey CJ, Rhodes CH, Roberts DW, Newton HB, Pipas JM.

J Neurooncol. 2008 Nov;90(2):229-35. doi: 10.1007/s11060-008-9655-9. Epub 2008 Jul 26.

33.

Folic acid fortification and cancer risk.

Mason JB, Cole BF, Baron JA, Kim YI, Smith AD.

Lancet. 2008 Apr 19;371(9621):1335; author reply 1335-6. doi: 10.1016/S0140-6736(08)60590-5. No abstract available.

PMID:
18424321
34.

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Thürlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Price KN, Goldhirsch A, Viale G, Gusterson BA; International Breast Cancer Study Group.

Ann Oncol. 2008 Aug;19(8):1393-401. doi: 10.1093/annonc/mdn123. Epub 2008 Apr 2.

35.

Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.

Bakari M, Arbeit RD, Mtei L, Lyimo J, Waddell R, Matee M, Cole BF, Tvaroha S, Horsburgh CR, Soini H, Pallangyo K, von Reyn CF.

BMC Infect Dis. 2008 Mar 6;8:32. doi: 10.1186/1471-2334-8-32.

36.

Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.

Titus-Ernstoff L, Troisi R, Hatch EE, Hyer M, Wise LA, Palmer JR, Kaufman R, Adam E, Noller K, Herbst AL, Strohsnitter W, Cole BF, Hartge P, Hoover RN.

Epidemiology. 2008 Mar;19(2):251-7. doi: 10.1097/EDE.0b013e318163152a.

PMID:
18223485
37.

Cognitive function in breast cancer patients prior to adjuvant treatment.

Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA.

Breast Cancer Res Treat. 2008 Jul;110(1):143-52. Epub 2007 Aug 3.

38.

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

Gianni L, Cole BF, Panzini I, Snyder R, Holmberg SB, Byrne M, Crivellari D, Colleoni M, Aebi S, Simoncini E, Pagani O, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Ravaioli A.

Support Care Cancer. 2008 Jan;16(1):67-74. Epub 2007 Jul 13.

PMID:
17629752
39.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group.

JAMA. 2007 Jun 6;297(21):2351-9.

PMID:
17551129
40.

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.

Karlsson P, Cole BF, Price KN, Coates AS, Castiglione-Gertsch M, Gusterson BA, Murray E, Lindtner J, Collins JP, Holmberg SB, Fey MF, Thürlimann B, Crivellari D, Forbes JF, Gelber RD, Goldhirsch A, Wallgren A.

J Clin Oncol. 2007 May 20;25(15):2019-26. Epub 2007 Apr 9.

PMID:
17420511
41.

Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang.

Ernstoff MS, Crocenzi TS, Seigne JD, Crosby NA, Cole BF, Fisher JL, Uhlenhake JC, Mellinger D, Foster C, Farnham CJ, Mackay K, Szczepiorkowski ZM, Webber SM, Schned AR, Harris RD, Barth RJ Jr, Heaney JA, Noelle RJ.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):733s-740s. Review.

42.

Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.

Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, Beck GJ, Summers RW, Barry EL, Cole BF, Snover DC, Rothstein R, Mandel JS.

J Natl Cancer Inst. 2007 Jan 17;99(2):129-36.

PMID:
17227996
43.

Factors associated with atypical moles in New Hampshire, USA.

Titus-Ernstoff L, Ding J, Perry AE, Spencer SK, Cole BF, Ernstoff MS.

Acta Derm Venereol. 2007;87(1):43-8.

44.

SunSafe in the Middle School Years: a community-wide intervention to change early-adolescent sun protection.

Olson AL, Gaffney C, Starr P, Gibson JJ, Cole BF, Dietrich AJ.

Pediatrics. 2007 Jan;119(1):e247-56.

PMID:
17200250
45.

Cognitive-behavioral management of chemotherapy-related cognitive change.

Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA.

Psychooncology. 2007 Aug;16(8):772-7.

46.

Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.

Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF.

J Infect Dis. 2007 Jan 1;195(1):118-23. Epub 2006 Nov 20.

47.

Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).

Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS.

Cancer Causes Control. 2006 Dec;17(10):1299-304.

PMID:
17111262
48.

Perinatal factors, growth and development, and osteosarcoma risk.

Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN.

Br J Cancer. 2006 Dec 4;95(11):1603-7. Epub 2006 Nov 14.

49.

Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies.

Troisi R, Vatten L, Hoover RN, Roberts JM, Cole BF, Potischman N.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):2013-5.

50.

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.

Omlin A, Amichetti M, Azria D, Cole BF, Fourneret P, Poortmans P, Naehrig D, Miller RC, Krengli M, Gutierrez Miguelez C, Morgan D, Goldberg H, Scandolaro L, Gastelblum P, Ozsahin M, Dohr D, Christie D, Oppitz U, Abacioglu U, Gruber G.

Lancet Oncol. 2006 Aug;7(8):652-6.

PMID:
16887482

Supplemental Content

Support Center